Parkinson’s disease has long been defined by the slow, relentless loss of dopamine-producing neurons, with treatments focused ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

Initiation of trial marks first-in-human milestone for Neomorph's novel molecular glue degrader platformSAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering ...

Dosing the first patient in our Phase 1/2 trial of NEO-811 in renal cell carcinoma marks a pivotal inflection point for Neomorph, representing the first clinical evaluation of an asset from our ...

Radiotherapy is one of the main treatment forms for cancer. Among its most common side effects is skin damage, right up to chronic inflammation and fibroses. At present, such long-term damage can only ...

The protein Dickkopf 3 plays a key role in the development of radiation-induced fibroses - and could be a promising target ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, function, and interactions. Proteomics plays a critical role in understanding ...

Prof. Terence Lee, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology, and his ...

In new research published in the journal Nature Communications, scientists at the University of Florida and Linköping ...

Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University ...

Researchers identify beta catenin protein degradation as a therapeutic vulnerability in B cell acute lymphoblastic leukaemia, supporting the repurposing of glycogen synthase kinase 3 beta inhibitors.

Researchers show that loss of the SPRTN enzyme lets DNA–protein crosslinks accumulate, leak DNA into the cytoplasm, activate ...